DOI: https://doi.org/10.24959/nphj.17.2184

The study of hypolipidemic properties of Ginger extract on the model of type 2 diabetes induced by dexamethasone

N. M. Kononenko, V. V. Chikitkina, M. V. Sorokina, M. O. Ostapets

Abstract


Aim. To study experimentally the hypolipidemic properties of Ginger extract against the background of type 2 diabetes.

Materials and methods. The study of the hypolipidemic properties of Ginger extract was performed by the lipid metabolism indices on the model of type 2 diabetes induced by dexamethasone in rats aged 18 months.

Results and discussion. Experimental type 2 diabetes was accompanied with disorder of the lipid metabolism, it was confirmed by the increase of the content triacylglycerides, atherogenic apoB-lipoproteins with simultaneous reduction of high-density lipoproteins and increased release of free fatty acids from the adipose tissue. Under the effect of Ginger extract in the doses of 50 and 80 mg/kg the level of free fatty acids in the blood serum decreased by 38.4 % and 38.9 %, probably due to correction of insulin resistance manifestations and preservation of the insulin control effect on lipolysis. The reliable inhibition of hypertriacylglycerolemia severity by Ginger extract in the dose of 80 mg/kg by 35.1% correlated with a decrease of apoB-LP production in the liver, and it indicated correction of diabetic dyslipidemia. At the same time, the level of the antiatherogenic fraction – high-density lipoproteins – significantly increased by 26.1 and 29.5 % under the effect of the extract in the doses of 50 and 80 mg/kg, respectively, compared to the values of animals of the control pathology. Ginger extract in the dose of 80 mg/kg showed a more expressive ability to normalize the lipid metabolism at the level of the reference drug – “Arphasetin” herbal medicinal product.

Conclusions. Introduction of Ginger extract for 14 days in the doses of 50 and 80 mg/kg on the model of type 2 diabetes induced by dexamethasone was accompanied with a reliable normalization of the lipid metabolism. The use of Ginger extract in the dose of 80 mg/kg is most pronounced at the level of the reference drug – “Arphasetin” herbal medicinal product, corrected the pathological changes in the lipid metabolism characteristic for type 2 diabetes. It allows making a conclusion concerning the feasibility of further studies of the extract exactly in this dose and the prospects of its use as an antiatherogenic drug in the complex treatment of type 2 diabetes.


Keywords


Ginger extract; type 2 diabetes mellitus; dexamethasone; hypolipidemic action

Full Text:

PDF

References


Cheng, D. (2005). Prevalence, predisposition and prevention of type II diabetes. Nutrition and metabolism, 2.London, 29.

Lorenzati, B., Zucco, C., Miglietta, S., Lamberti, F., Bruno, G. (2010). Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action. Pharmaceuticals, 3 (9), 3005–3020. doi: 10.3390/ph3093005

Kvasova, T. M. (2012). Issledovanie gipoglikemicheskikh svoistv i khimicheskogo sostava novogo vodorastvorimogo ekstrakta sbora arfazetin sukhogo. Tver, 146.

Chekman, І. S., Bondur, V. V., Klimenko, O. V. (2016). Ratcionalnaia farmakoterapiia, 2 (39), 25–31.

Karuppiah, P., Rajaram, S. (2012). Antibacterial effect of Allium sativum cloves and Zingiber officinale rhizomes against multiple–drug resistant clinical pathogens. Asian Pacific Journal of Tropical Biomedicine, 2 (8), 597–601. doi: 10.1016/s2221–1691(12)60104–x

Funk, J. L., Frye, J. B., Oyarzo, J. N., Chen, J., Zhang, H., Timmermann, B. N. (2016). Anti–inflammatory effects of the essential oils of ginger (Zingiber officinale Roscoe) in experimental rheumatoid arthritis. PharmaNutrition, 4 (3), 123–131. doi: 10.1016/j.phanu.2016.02.004

Rastogi, N., Duggal, S., Singh, S. K., Porwal, K., Srivastava, V. K., Maurya, R., Mishra, D. P. (2015). Proteasome inhibition mediates p53 reactivation and anti–cancer activity of 6–Gingerol in cervical cancer cells. Oncotarget, 6 (41), 43310–43325. doi: 10.18632/oncotarget.6383

Li, Y., Tran, V. H., Kota, B. P., Nammi, S., Duke, C. C., Roufogalis, B. D. (2014). Preventative Effect of Zingiber officinaleon Insulin Resistance in a High–Fat High–Carbohydrate Diet–Fed Rat Model and its Mechanism of Action. Basic & Clinical Pharmacology & Toxicology, 115 (2), 209–215. doi: 10.1111/bcpt.12196

Račková, L., Cupáková, M., Ťažký, A., Mičová, J., Kolek, E., Košťálová, D. (2013). Redox properties of ginger extracts: Perspectives of use of Zingiber officinale Rosc. as antidiabetic agent. Interdisciplinary Toxicology, 6 (1). doi: 10.2478/intox–2013–0005

Stefanov, O. V. (2001). Doklіnіchnі doslіdzhennia lіkarskykh zasobіv. Kyiv: Avіtsena, 528.

Klimov, A. N., Loviagina, T. N., Bankovskaia, E. B. (1966). Laboratornoe delo, 5, 276–279.

Wakil, S. J., Abu–Elheiga, L. A. (2008). Fatty acid metabolism: target for metabolic syndrome. Journal of Lipid Research, 50 (Supplement), S138–S143. doi: 10.1194/jlr.r800079–jlr200


GOST Style Citations


1.         Cheng, D. Prevalence, predisposition and prevention of type II diabetes / D. Cheng // Nutrition and Metabolism. –London, 2005. – Vol. 2. – 29 p.

2.         Oral hypoglycemic drugs : Pathophysiological basis of their mechanism of action / B. Lorenzati, C. Zucco, S. Miglietta et al. // Pharmaceuticals. – 2010. – Vol. 3, Issue 9. – Р. 3005–3020. doi: 10.3390/ph3093005

3.         Квасова, Т. М. Исследование гипогликемических свойств и химического состава нового водорастворимого экстракта сбора арфазетин сухого : дис. ... канд. биол. наук : 14.03.06 / Т. М. Квасова. – Тверь, 2012. – 146 с.

4.         Чекман, І. С. Комбінована фармакотерапія цукрового діабету 2–го типу / І. С. Чекман, В. В. Бондур, О. В. Клименко // Рациональная фармакотерапия. – 2016. – № 2 (39). – С. 25–31.

5.         Karuppiah, P. Antibacterial effect of Allium sativum cloves and Zingiber officinale rhizomes against multiple–drug resistant clinical pathogens / P. Karuppiah, S. Rajaram // Asian Pacific J. of Tropical Biomed. – 2012. – Vol. 2, Issue 8. – P. 597–601. doi: 10.1016/s2221–1691(12)60104–x

6.         Anti–inflammatory effect of the essential oils of Ginger (Zingiber officinale Roscoe) in experimental rheumatoid arthritis / J. L. Funk, J. B. Frye, J. N. Oyarzo et al. // PharmaNutrition. – 2016. – Vol. 4, Issue 3. – Р. 123–131. doi: 10.1016/j.phanu.2016.02.004

7.         Proteasome inhibition mediates p53 reactivation and anti–cancer activity of 6–gingerol in cervical cancer cells / N. Rastogi,S. Duggal, S. K. Singh et al. // Oncotarget. – 2015. – Vol. 6, Issue 41. – Р. 43310–43325. doi: 10.18632/oncotarget.6383

8.         Preventative effect of Zingiber officinale on insulin resistance in a high–fat high–carbohydrate diet–fed rat model and its mechanism of action / Y. Li, V. H. Tran, B. P. Kota et al. // Basic and Clinical Pharmacol. and Toxicol. – 2014. – Vol. 115, Issue 2. – P. 209–215. doi: 10.1111/bcpt.12196

9.         Redox properties of ginger extracts: Perspectives of use of Zingiber officinale Rosc. as antidiabetic agent / L. Račková, M. Cupáková, A. Tažký et al. // Interdisciplinary Toxicol. – 2013. – Vol. 6, Issue 1. – Р. 26–33. doi: 10.2478/intox–2013–0005

10.       Доклінічні дослідження лікарських засобів : метод. рек. / за ред. член–кор. НАМН України О. В. Стефанова. – К. : Авіценна, 2001. – 528 с.

11.       Климов, А. Н. Турбидиметрический метод определения β–липопротеидов и хиломикронов в сыворотке крови и тканях / А. Н. Климов, Т. Н. Ловягина, Э. Б. Баньковская // Лабораторное дело. – 1966. – Т. 5. – С. 276–279.

12.       Wakil, S. J. Fatty acid metabolism : target for metabolic syndrome / S. J. Wakil, L. A. Abu–Elheiga // J. of Lipid Res. – 2009. – Vol. 50. – P. S138–S143. doi: 10.1194/jlr.r800079–jlr200





Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Abbreviated key title: Vìsn. farm.

ISSN 2415-8844 (Online), ISSN 1562-7241 (Print)